z-logo
open-access-imgOpen Access
Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart
Author(s) -
Anne Van Steenbergen,
Magali Balteau,
Audrey Ginion,
Laura Ferté,
Sylvain Battault,
Christophe de Meester,
JeanLuc Balligand,
Evangelos-Panagiotis Daskalopoulos,
Patrick Gilon,
Florin Despa,
Sanda Despa,
JeanLouis Vanoverschelde,
Sandrine Horman,
Hermann Koepsell,
Gerard T. Berry,
Louis Hue,
Luc Bertrand,
Christophe Beauloye
Publication year - 2017
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/srep41166
Subject(s) - nadph oxidase , reactive oxygen species , cotransporter , medicine , gene isoform , endocrinology , chemistry , downregulation and upregulation , diabetic cardiomyopathy , sodium , cardiomyopathy , biochemistry , biology , heart failure , gene , organic chemistry
Hyperglycemia (HG) stimulates the production of reactive oxygen species in the heart through activation of NADPH oxidase 2 (NOX2). This production is independent of glucose metabolism but requires sodium/glucose cotransporters (SGLT). Seven SGLT isoforms (SGLT1 to 6 and sodium-myoinositol cotransporter-1, SMIT1) are known, although their expression and function in the heart remain elusive. We investigated these 7 isoforms and found that only SGLT1 and SMIT1 were expressed in mouse, rat and human hearts. In cardiomyocytes, galactose (transported through SGLT1) did not activate NOX2. Accordingly, SGLT1 deficiency did not prevent HG-induced NOX2 activation, ruling it out in the cellular response to HG. In contrast, myo-inositol (transported through SMIT1) reproduced the toxic effects of HG. SMIT1 overexpression exacerbated glucotoxicity and sensitized cardiomyocytes to HG, whereas its deletion prevented HG-induced NOX2 activation. In conclusion, our results show that heart SMIT1 senses HG and triggers NOX2 activation. This could participate in the redox signaling in hyperglycemic heart and contribute to the pathophysiology of diabetic cardiomyopathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom